NASDAQ:GH
Guardant Health, Inc.
Guardant Health, Inc.'s revenue grew 32.9% in fiscal 2025 to $982.0M while operating margin rose to −44.5%. Free cash flow was −$233.1M, −23.7% of revenue, and the diluted share count rose 2.1%.Summary generated from Guardant Health, Inc.'s SEC filings. Latest annual report filed Feb 19, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$982.0M
Revenue growth+32.9%
Revenue, 5-yr CAGR+27.9%
Gross margin64.5%
Operating margin−44.5%
Net margin−42.4%
ROIC−45.9%
Return on equityn/a
Debt / equityn/a
Free cash flow−$233.1M
FCF margin−23.7%
Share count change+2.1%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 374 | 450 | 564 | 739 | 982 |
| Operating income | −411 | −544 | −565 | −444 | −437 |
| Net income | −385 | −655 | −479 | −436 | −416 |
| Free cash flow | −284 | −387 | −345 | −275 | −233 |
Recent filings
- 4Insider transaction report
Oct 2, 2026 - 4Insider transaction report
Oct 2, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 30, 2026 - 8-KResults of operations and financial condition
Jul 30, 2026 - 8-KResults of a shareholder vote
Jun 18, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 7, 2026 - 8-KResults of operations and financial condition
May 7, 2026 - DEF 14AProxy statement
Apr 28, 2026